ORCID as entered in ROS
![orcid_icon](/themes/resgate8/images/icons/ORCIDiD_icon24x24.png)
Select Publications
2012, 'APPLICATION OF FLII NEUTRALIZING ANTIBODIES REDUCES THE SEVERITY OF SKIN BLISTERING IN A COLVII MODEL OF EPIDERMOLYSIS BULLOSA ACQUISITA', WOUND REPAIR AND REGENERATION, 20, pp. A60 - A60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308945000032&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'BORON-BASED AN2728 AND AN2898 OINTMENTS DEMONSTRATE SAFETY AND EFFICACY IN A PHASE 2A BILATERAL STUDY OF MILD-TO-MODERATE ATOPIC DERMATITIS', WOUND REPAIR AND REGENERATION, 20, pp. A69 - A69, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308945000067&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'INVESTIGATION OF CELL THERAPY FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA (RDEB) THROUGH INTRADERMAL INJECTION OF ALLOGENEIC FIBROBLASTS RANDOMIZED AGAINST PLACEBO INJECTIONS OF SUSPENSION SOLUTION', WOUND REPAIR AND REGENERATION, 20, pp. A68 - A68, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308945000061&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'PODIATRY ASSESSMENT FOR EPIDERMOLYSIS BULLOSA', WOUND REPAIR AND REGENERATION, 20, pp. A72 - A72, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308945000081&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'REVIEW OF SIDE EFFECTS OF IMMUNOSUPPRESSIVE AGENTS USED FOR AUTOIMMUNE BLISTERING DISEASES', WOUND REPAIR AND REGENERATION, 20, pp. A76 - A76, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308945000095&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'USE OF CETUXIMAB AS AN ADJUVANT AGENT TO RADIOTHERAPY AND SURGERY IN RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA WITH SQUAMOUS CELL CARCINOMA', WOUND REPAIR AND REGENERATION, 20, pp. A60 - A60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308945000030&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'VALIDATION OF THE PSYCHOMETRIC PROPERTIES OF A QUALITY-OF-LIFE MEASURE SPECIFIC TO AUTOIMMUNE BULLOUS DISEASE', WOUND REPAIR AND REGENERATION, 20, pp. A65 - A65, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308945000051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'Corticosteroid Use in Autoimmune Blistering Diseases', Immunology and Allergy Clinics of North America, 32, pp. 283 - 294, http://dx.doi.org/10.1016/j.iac.2012.04.008
,2012, 'Diagnosis and Clinical Features of Pemphigus Vulgaris', Immunology and Allergy Clinics of North America, 32, pp. 233 - 243, http://dx.doi.org/10.1016/j.iac.2012.04.003
,2012, 'Rituximab and its Use in Autoimmune Bullous Disorders', Immunology and Allergy Clinics of North America, 32, pp. 331 - 337, http://dx.doi.org/10.1016/j.iac.2012.04.013
,2012, 'The Use of Intravenous Immunoglobulin in Autoimmune Bullous Diseases', Immunology and Allergy Clinics of North America, 32, pp. 323 - 330, http://dx.doi.org/10.1016/j.iac.2012.04.012
,2012, 'Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts.', Journal of the American Academy of Dermatology, 66, pp. 479 - 485, http://dx.doi.org/10.1016/j.jaad.2011.06.032
,2012, 'Diverse presentations of carcinoma erysipelatoides from a teaching hospital in australia.', Case Rep Dermatol Med, 2012, pp. 134938, http://dx.doi.org/10.1155/2012/134938
,2012, 'Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma complicating patients with recessive dystrophic epidermolysis bullosa.', Cancer Research, 72, pp. 3522 - 3534, http://dx.doi.org/10.1158/0008-5472.CAN-11-2996
,2012, 'Inherited epidermolysis bullosa: New diagnostic criteria and classification', Clinics in Dermatology, 30, pp. 70 - 77, http://dx.doi.org/10.1016/j.clindermatol.2011.03.012
,2012, 'Population-Specific Association between a Polymorphic Variant in ST18, Encoding a Pro-Apoptotic Molecule, and Pemphigus Vulgaris.', Journal of Investigative Dermatology, 132, pp. 1798 - 1805, http://dx.doi.org/10.1038/jid.2012.46
,2012, 'Quality-of-Life Measurement in Blistering Diseases', Dermatologic Clinics, 30, pp. 301 - 307, http://dx.doi.org/10.1016/j.det.2011.11.008
,2012, 'Severity score indexes for blistering diseases', Clinics in Dermatology, 30, pp. 108 - 113, http://dx.doi.org/10.1016/j.clindermatol.2011.03.017
,2012, 'Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting.', Allergy, 67, pp. 1111 - 1117, http://dx.doi.org/10.1111/j.1398-9995.2012.02874.x
,2011, 'Adolescent acne', Australian Doctor, pp. 39 - 40
,2011, 'Treating psoriasis', Australian Doctor, pp. 37 - 38
,2011, 'Erythema Multiforme, Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis', , 1, pp. 1 - 8, http://dx.doi.org/10.1002/9781444345384.ch78
,2011, 'Atopic dermatitis', Australian Doctor, pp. 35 - 36
,2011, 'A systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus', Journal of the American Academy of Dermatology, 64, pp. 903 - 908, http://dx.doi.org/10.1016/j.jaad.2010.04.039
,2011, 'Advancement of women in dermatology', International Journal of Dermatology, 50, pp. 593 - 600, http://dx.doi.org/10.1111/j.1365-4632.2011.05075.x
,2011, 'Bullous Systemic Lupus Erythematosus', Dermatologic Clinics, 29, pp. 649 - 653, http://dx.doi.org/10.1016/j.det.2011.06.002
,2011, 'Corticosteroid Use in Autoimmune Blistering Diseases', Dermatologic Clinics, 29, pp. 535 - 544, http://dx.doi.org/10.1016/j.det.2011.06.004
,2011, 'Current Management Strategies in Paraneoplastic Pemphigus (Paraneoplastic Autoimmune Multiorgan Syndrome)', Dermatologic Clinics, 29, pp. 607 - 612, http://dx.doi.org/10.1016/j.det.2011.06.016
,2011, 'Epidermolysis bullosa with late-onset muscular dystrophy and plectin deficiency', Muscle and Nerve, 44, pp. 135 - 141, http://dx.doi.org/10.1002/mus.22076
,2011, 'Evidence-Based Management of Bullous Pemphigoid', Dermatologic Clinics, 29, pp. 613 - 620, http://dx.doi.org/10.1016/j.det.2011.06.003
,2011, 'Infection and Infection Prevention in Patients Treated with Immunosuppressive Medications for Autoimmune Bullous Disorders', Dermatologic Clinics, 29, pp. 591 - 598, http://dx.doi.org/10.1016/j.det.2011.06.021
,2011, 'Management of Epidermolysis Bullosa Acquisita', Dermatologic Clinics, 29, pp. 643 - 647, http://dx.doi.org/10.1016/j.det.2011.06.020
,2011, 'Overexpression of the Flii gene increases dermal-epidermal blistering in an autoimmune ColVII mouse model of epidermolysis bullosa acquisita', Journal of Pathology, 225, pp. 401 - 413, http://dx.doi.org/10.1002/path.2973
,2011, 'Pemphigoid Gestationis: Current Management', Dermatologic Clinics, 29, pp. 621 - 628, http://dx.doi.org/10.1016/j.det.2011.06.013
,2011, 'Rituximab and its Use in Autoimmune Bullous Disorders', Dermatologic Clinics, 29, pp. 571 - 575, http://dx.doi.org/10.1016/j.det.2011.06.023
,2011, 'The Autoimmune Blistering Diseases in Australia: Status and Services', Dermatologic Clinics, 29, pp. 687 - 690, http://dx.doi.org/10.1016/j.det.2011.07.002
,2011, 'The International Pemphigus and Pemphigoid Foundation', Dermatologic Clinics, 29, pp. 655 - 657, http://dx.doi.org/10.1016/j.det.2011.06.019
,2011, 'The Use of Intravenous Immunoglobulin in Autoimmune Bullous Diseases', Dermatologic Clinics, 29, pp. 565 - 570, http://dx.doi.org/10.1016/j.det.2011.06.010
,2010, 'Diagnosis and prevention of bullous diseases', , pp. 115 - 135, http://dx.doi.org/10.1007/978-1-84996-021-2_12
,2010, 'Adult onset muscular dystrophy associated with epidermolysis bullosa simplex and plectin deficiency - the first Australian case and genotype-phenotype correlations', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 51, pp. A8 - A9, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000284242800040&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'Complete resolution of chronic multiple verruca vulgaris treated with quadrivalent human papilloma virus (HPV) vaccine', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 51, pp. A9 - A9, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000284242800042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'Dystrophic epidermolysis bullosa compound heterozygote presents with immunofluorescence findings evocative of transient bullous dermolysis of the newborn', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 51, pp. A8 - A8, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000284242800039&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'Responsiveness of nonHerlitz Junctional Epidermolysis Bullosa to topical gentian violet', International Journal of Dermatology, 49, pp. 1282 - 1285, http://dx.doi.org/10.1111/j.1365-4632.2010.04557.x
,2010, 'TRIAL OF FIBROBLAST CELL THERAPY FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA', WOUND REPAIR AND REGENERATION, 18, pp. A74 - A74, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000279454700063&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'Epidemiology of epidermolysis bullosa in the antipodes: The Australasian epidermolysis bullosa registry with a focus on Herlitz junctional epidermolysis bullosa', Archives of Dermatology, 146, pp. 635 - 640, http://dx.doi.org/10.1001/archdermatol.2010.109
,2010, 'Phenotypic variability associated with WNT10A nonsense mutations', British Journal of Dermatology, 162, pp. 1403 - 1406, http://dx.doi.org/10.1111/j.1365-2133.2010.09703.x
,2010, 'Recalcitrant cutaneous warts treated with recombinant quadrivalent human papillomavirus vaccine (types 6, 11, 16, and 18) in a developmentally delayed, 31-year-old white man', Archives of Dermatology, 146, pp. 475 - 477, http://dx.doi.org/10.1001/archdermatol.2010.71
,2010, 'Epidermolysis bullosa in Australia and New Zealand', Dermatologic Clinics, 28, pp. 433 - 438, http://dx.doi.org/10.1016/j.det.2010.02.009
,2010, 'Fibroblast-based cell therapy strategy for recessive dystrophic epidermolysis bullosa', Dermatologic Clinics, 28, pp. 367 - 370, http://dx.doi.org/10.1016/j.det.2010.01.015
,2010, 'How to take skin biopsies for epidermolysis bullosa', Dermatologic Clinics, 28, pp. 197 - 200, http://dx.doi.org/10.1016/j.det.2009.12.002
,